Fantasy Football - Footballguys Forums

Recommended Posts

On 2/15/2020 at 3:50 PM, culdeus said:

This is like two weeks old no?

Not that I'm aware.

... unless the media is also very late to the party:

INO Corona

INO Motley Fool

Quote

"The bad news is that Inovio has never actually developed a commercial-stage vaccine. Despite being in business for 40 years, the company is only now on the cusp of generating late-stage data for one of its DNA-based therapies. Specifically, Inovio is slated to roll out top-line data for VGX-3100 as a treatment for cervical dysplasia in the fourth-quarter of 2020.

Another worrying sign is that this isn't the first time Inovio's stock has skyrocketed in response to an infectious disease threat. In 2016, for instance, the biotech's shares took flight after it announced plans to tackle the Zika virus. Per the company's latest clinical update in early 2020, however, its Zika virus product candidate hasn't even made it past a phase 1 trial yet. So investors should probably take this hype over a COVID-19 virus vaccine with a huge grain of salt.  

Time to buy?

If your sole purpose is to own a company likely to benefit from the COVID-19 threat, Inovio probably isn't your best bet. The company has never brought a product to market in four decades, much to the detriment of long-suffering shareholders. Since going public, in fact, Inovio's stock has produced a negative return on capital of 92.7%. Perhaps this story will change for the better with a positive late-stage readout for VGX-3100 later this year. But until then, investors should probably curb their enthusiasm. "

Edited by Bossman

Share this post


Link to post
Share on other sites
2 hours ago, Bossman said:

Not that I'm aware.

... unless the media is also very late to the party:

INO Corona

INO Motley Fool

Quote

"The bad news is that Inovio has never actually developed a commercial-stage vaccine. Despite being in business for 40 years, the company is only now on the cusp of generating late-stage data for one of its DNA-based therapies. Specifically, Inovio is slated to roll out top-line data for VGX-3100 as a treatment for cervical dysplasia in the fourth-quarter of 2020.

Another worrying sign is that this isn't the first time Inovio's stock has skyrocketed in response to an infectious disease threat. In 2016, for instance, the biotech's shares took flight after it announced plans to tackle the Zika virus. Per the company's latest clinical update in early 2020, however, its Zika virus product candidate hasn't even made it past a phase 1 trial yet. So investors should probably take this hype over a COVID-19 virus vaccine with a huge grain of salt.  

Time to buy?

If your sole purpose is to own a company likely to benefit from the COVID-19 threat, Inovio probably isn't your best bet. The company has never brought a product to market in four decades, much to the detriment of long-suffering shareholders. Since going public, in fact, Inovio's stock has produced a negative return on capital of 92.7%. Perhaps this story will change for the better with a positive late-stage readout for VGX-3100 later this year. But until then, investors should probably curb their enthusiasm. "

I had some money sitting around in one account and decided to buy a meager one hundred shares @ $3.25 each on the 7th of this month. Closed @ $4.15 last Friday. Did a little research and thought, why not get a few shares. As of now, planning on holding due to the coronavirus situation. Obviously I'm not looking to break the bank here, just maybe take some modest profit sometime down the line.  

 

ETA: wrote the closing number down wrong, posted $4.25 when it was actually $4.15

Edited by drunken slob
Corrected price

Share this post


Link to post
Share on other sites
12 minutes ago, The Lost One said:

Any of you guys subscribe to the Motley Fool?  They always feel like they have some available package for $2000, which they work down to $799 when you don't buy it away first. Seems like they're trying to prey in people's emotions but also that they seem to know what they're talking about. Just had a bull market package recently. 

Thoughts?

They offer a number of investment newsletters.  I've never delved into them, but they don't seem to be groundbreaking.  If you read anything there it's Saul's investing board.  That guy has done 30+% for the last decade, at least.  

They also have some really wacky political boards.  Way wackier than here.

  • Like 1

Share this post


Link to post
Share on other sites

I may be off base here but In my opinion I can't put much more stock into Motley Fool than I can in  the usual Sports picks Touts

As Ed Norton in Motherless Brooklyn would say, "Steve-o, Steve-n, Steve-Steve, Steve to da Steve Steve"

Stop messing with my mind m'f'er

Edited by Penguin

Share this post


Link to post
Share on other sites
On 2/15/2020 at 2:49 PM, Bossman said:

$INO claiming they now have a vaccine for Corona ... just hours after having access to the virus.

Might be worth throwing a few bucks at Tuesday.

 

Wow ... didn't realize stock prices moved this early.

$INO already up quite a bit. $AGRX starting to climb.

How do these move before pre-market hours? 

Share this post


Link to post
Share on other sites
1 hour ago, Bossman said:

Wow ... didn't realize stock prices moved this early.

$INO already up quite a bit. $AGRX starting to climb.

How do these move before pre-market hours? 

And now it’s down a couple percent. I don’t put much weight on after hours trading, myself. 

Share this post


Link to post
Share on other sites
10 hours ago, The Lost One said:

Any of you guys subscribe to the Motley Fool?  They always feel like they have some available package for $2000, which they work down to $799 when you don't buy it away first. Seems like they're trying to prey in people's emotions but also that they seem to know what they're talking about. Just had a bull market package recently. 

Thoughts?

They at times offer gigantic amounts of airline points for signup offers.  I don't recall them being near that expensive.  The content was pretty crap except they turned me onto convertible bonds in the 2010 timeframe which worked out. 

Share this post


Link to post
Share on other sites
On 2/14/2020 at 1:36 PM, dkp993 said:

This is why I ####### love FBG’s.  Never in a million years would one expect to get posts like this from a make believe football site!   

I’m going to need to reread this a few times to wrap my head around it but thank you sif for taking the time to post it and letting us crawl around in your thought process for a bit.  

I've been reading @siffoin posts for many years.  He actually is the one who got me started writing put options to pick up stocks I was interested in during a down trend.

  • Like 1

Share this post


Link to post
Share on other sites
On 2/13/2020 at 4:17 PM, siffoin said:

Spitballin' here.  And the comments are just for free - and worth every penny you pay for them.

#1) The market is bullish.  IMO it would take some time for it to actually turn bearish. By some time, I don't mean hours or days or weeks...I'm talking months.

2) The bull market is extremely over-extended.  By extreme what I mean is I'm of the opinion that there has never been a time if our lives where the market has been this far out of whack in regards to price:value.  Technically - it is what I would consider ripe for some type of correction.  That doesn't mean today is a top.  Or tomorrow.  But I would suggest that soon, it would be "natural" for the market to begin some corrective move - just to get back in-line with the bullish trend.  For example if the $SPY were to drop 20 points...we'd still be WAY over-valued and my opinion wouldn't change.   A 15-20% correction wouldn't move the needle on the LT bull trend.  At these current levels we are in dangerous territory if you care about that 15-20%.

3) I'm $GYPR(ing) to protect and prepare for opportunity if and when the market does decide to come back towards "balance".  It's not a time for panic - sell everything.  Rather a taking a calm perspective with future opportunity in mind.

4) So what to do:  You've got 15% sitting in cash.  Would you consider a hedge type of play on that?  For simplicity you might want to take a look at the ETF $TAIL.  It's a tail risk strategy that invests about 90% in US Treasuries and then out of the $ Puts on the $SPY. In a corrective move investors will tend to flee towards treasuries, volatility will increase (+ value to the puts), and the puts themselves will increase in value.  If we're wrong...$TAIL will  decline, but that loss will be off-set by the increase of your already held long positions.  In addition because the $VIX is pretty low, the timing is decent and $TAIL is pretty cheap.  If and when the corrective moves comes - look to unload at levels of support.  Right now that would be $290ish and $280ish - being attentive if the $SPY were dropping towards those levels and finding the right time for YOU to unload.  This isn't about being perfect.  It's about developing a plan for a "natural" corrective move and following that plan as it unfolds.

5) I'm hesitant to post this type of stuff because if I had my way I'd want "most" of you to make money. (I kid you Trump loving lunatics - I even want you to make money too- I guess that's the "socialist" in me).  Therefore, please do your own due diligence and mostly don't do something stupid because I posted something stupid.

I wish I understood any of this.

  • Thanks 1

Share this post


Link to post
Share on other sites
2 hours ago, Sputnikv8 said:

Can CYDY rally yet again or is this more like "CYalater"?  :popcorn:

Chet hasn't sold any shares. In fact, he's buying more tomorrow 

Share this post


Link to post
Share on other sites
3 hours ago, Foosball God said:

I wish I understood any of this.

Tdoss (imo): siff cares about trends and momentum. Don't be surprised if the market corrects soon, as it's overvalued by enough that you could see a significant short-term event that reduces the value of your stocks (painfully). 

Even if that happens (and siff thinks it's likely enough), that doesn't mean we go into long-term market sell off mode. It will take months of downward pressure to turn the upward market (bull) trend into a downward trending market (bear).

This has been Bob Sacamano with a dubmLABS exclusive report.

  • Like 2
  • Thanks 1
  • Laughing 1

Share this post


Link to post
Share on other sites

BOT 20k more today and will buy more this week.

Step up, sheeple.

Share this post


Link to post
Share on other sites
1 hour ago, chet said:

BOT 20k more today and will buy more this week.

Step up, sheeple.

Maybe if it goes below $1. Is there any type of news coming up anytime soon? I remember the app that was supposed to be done end of February. Is there any other news (not insider, but announced timetable) coming up? I do still have plenty more cash. Still kicking myself for not buying a bunch of stuff in October. Almost everything I did but in October is up 30-50% and almost everything I thought about is up 30-100%. SMH. I timed it right just keep too much cash on the sidelines.

Share this post


Link to post
Share on other sites
18 hours ago, Bob Sacamano said:

Tdoss (imo): siff cares about trends and momentum. Don't be surprised if the market corrects soon, as it's overvalued by enough that you could see a significant short-term event that reduces the value of your stocks (painfully). 

Even if that happens (and siff thinks it's likely enough), that doesn't mean we go into long-term market sell off mode. It will take months of downward pressure to turn the upward market (bull) trend into a downward trending market (bear).

This has been Bob Sacamano with a dubmLABS exclusive report.

I'm Siffoin and I approve this message.

  • Like 1
  • Laughing 1

Share this post


Link to post
Share on other sites

What’s the feeling on NYMT?

Guy my dad knows has been investing in this for years, even before the crash because of the dividend it offers. He’s done and continues to do very well with it.

Share this post


Link to post
Share on other sites

For those watching at home, if you come in and ask "What do you think about XYZ Stonk" it helps at least to link to it's google finance page for the peanut gallery here.

Share this post


Link to post
Share on other sites
16 hours ago, stbugs said:

Maybe if it goes below $1. Is there any type of news coming up anytime soon? I remember the app that was supposed to be done end of February. Is there any other news (not insider, but announced timetable) coming up? I do still have plenty more cash. Still kicking myself for not buying a bunch of stuff in October. Almost everything I did but in October is up 30-50% and almost everything I thought about is up 30-100%. SMH. I timed it right just keep too much cash on the sidelines.

Lots of possible catalysts.  BLA. Coronavirus, Cancer results, break through designation opinion from FDA.

https://medicalnewsfirst.com/the-quest-for-a-functional-cure-in-cancer-reaching-an-inflection-point/

Share this post


Link to post
Share on other sites

I'm up 14% on GOLD in less than 10 days... I was hoping for that in one year, I'm bullish long term, and I wish I had more, but I'm wildly conflicted about sitting tight, adding more, taking profit. 

What do you all do in this situation? I always get these wrong. I gameplan for if it falls, stays flat, rises... But I never really have a plan in place for such a quick powerful gain on something I want to own. 

Share this post


Link to post
Share on other sites
3 hours ago, chet said:

From the above link and describes the opportunity in a nutshell:

Quote

This could ultimately move cancer away from cancer specialists, and put treatment in the hands of the general practitioner. Imagine a world where your doctor diagnoses you with cancer matter of factly, and prescribes you with a weekly injectable like what diabetics take until they do so imaging and see how well your tumor is shrinking without experiencing any toxic side effects.  This could be a reality in as soon as 30 days but what is hardest to fathom about this story is how the company with full rights to leronlimab and a potential functional cure for metastatic cancer is currently worth only $600 million.     

 

  • Like 1

Share this post


Link to post
Share on other sites
2 hours ago, fantasycurse42 said:

I'm up 14% on GOLD in less than 10 days... I was hoping for that in one year, I'm bullish long term, and I wish I had more, but I'm wildly conflicted about sitting tight, adding more, taking profit. 

What do you all do in this situation? I always get these wrong. I gameplan for if it falls, stays flat, rises... But I never really have a plan in place for such a quick powerful gain on something I want to own. 

For me in that case I'll usually go:

50% sidelines / 50% in play 


Admittedly that's generally not an everyday occurrence for me, :lol: but that's my mindset. 

Edited by [icon]

Share this post


Link to post
Share on other sites

You thought you'd make 14% in a year. Was the goal to own gold in a year or to make 14%?

If the goal was to make 14%, mission accomplished. What do you do with that money next? Where is the next 14%?  Move it to whatever can best accomplish your next goal. Maybe it's in gold. You say you're bullish on it. If that meets your next investing criteria, keep it there. How will you feel in a year if it's up another 14%? How will you feel if it's back to your purchase price?

If the goal was to own gold in a year, then 14% higher price now doesn't really change anything.

Share this post


Link to post
Share on other sites
3 hours ago, fantasycurse42 said:

I'm up 14% on GOLD in less than 10 days... I was hoping for that in one year, I'm bullish long term, and I wish I had more, but I'm wildly conflicted about sitting tight, adding more, taking profit. 

What do you all do in this situation? I always get these wrong. I gameplan for if it falls, stays flat, rises... But I never really have a plan in place for such a quick powerful gain on something I want to own. 

All my positions are long term so I usually let them ride. One of my stocks went up 18% today and it’s up @ 35% in 3 weeks. I’m hoping for multiples in 5 years so a nice day but not going anywhere. Still kicking myself for not throwing the rest of my cash in back in October or even 3 weeks ago. I’m happy with the returns on the investments but it’d be better to have more positions and be a bit more diversified. Again, I’m looking really long term. I’ve got more than enough cash for a while and I sure as #### don’t want to pay income tax on capital gains. That’s crazy.

Actually, definitely think about that. If you make a decent wage, you are paying federal and I think state taxes on that 14% if you sell it right away. That could be 5-6% gains gone.

Share this post


Link to post
Share on other sites

I am feeling a similar feel with CYDY as I did in the late fall when I was buying as many shares as I could in the ~$0.30 range.  I knew the stock was going to go higher but I didn't know when.  Same feeling now.  I buy a little every day but also watch for the news that will propel the share price higher.  

Anyway, GLTA.

  • Like 1

Share this post


Link to post
Share on other sites

You, too, Chet. If nothing else, you've given me a needed distraction and some good entertainment between reading job descriptions. So thanks for that.

  • Like 2

Share this post


Link to post
Share on other sites

The quad up from $.28-.29 isn't exactly a kick in the balls either.

  • Thanks 1

Share this post


Link to post
Share on other sites
2 minutes ago, Bob Sacamano said:

The quad up from $.28-.29 isn't exactly a kick in the balls either.

Yeah, I've added ~40% to my holding since the move up and I keep telling myself that I should have put the money to work at $0.30.  Not a fair complaint though because the story has been significantly de-risked since then.  Here's to treatment for Coronavirus and metastatic cancer!

Share this post


Link to post
Share on other sites

Good luck to the CYDY longs. 
 

While I have no position in the stock, I remain highly skeptical of the company’s long term outlook. I’ll share some of my reasons if there is interest.

Share this post


Link to post
Share on other sites
1 hour ago, Whyatt said:

Good luck to the CYDY longs. 
 

While I have no position in the stock, I remain highly skeptical of the company’s long term outlook. I’ll share some of my reasons if there is interest.

Of course, great to hear all views. 

  • Thanks 1

Share this post


Link to post
Share on other sites

Ok. I think it’s important to note the article linked by Chet was paid for by CytoDyn. Here is medicalnews1 pricing https://mn1.org/pricing   

CytoDyn has several of these arrangements, clearly promoting the stock is important to their business model.

Regarding cancer, note all the excitement is over a few early results, which Culper covers well in their report. Here is the competition https://www.mrknewsroom.com/news-release/oncology/mercks-keytruda-pembrolizumab-combination-chemotherapy-met-primary-endpoint-pr  Note this was success for mTBC, with 800+ patient enrollment. Also note the 1000+ ongoing clinical trial for Keytruda, vs CytoDyn’s single trial. The statement in the article that cancer treatment is changing in 30 day is 100% ridiculous. While I don’t think CytoDyn will sell any product at all in 2020, there is virtually zero chance they will commercialize for cancer in 2020.

The Coronavirus indication is a complete non starter. A quick google anyone can see many realistic candidates being investigated/trialed, none are cytodyn’s option.

Viewing the CytoDyn video attached to this page, I noticed the CEO mentioned HIV was the top indication for the drug. He is right. I think the upside is detailed in the Culper report. I have some insight on the upcoming competition in this market.

Fire away with comments, questions, and criticism.

 

Edited by Whyatt
Clarify my point- No cancer sales in 2020
  • Like 1
  • Thanks 1

Share this post


Link to post
Share on other sites
4 hours ago, Whyatt said:

Ok. I think it’s important to note the article linked by Chet was paid for by CytoDyn. Here is medicalnews1 pricing https://mn1.org/pricing   

CytoDyn has several of these arrangements, clearly promoting the stock is important to their business model.

Regarding cancer, note all the excitement is over a few early results, which Culper covers well in their report. Here is the competition https://www.mrknewsroom.com/news-release/oncology/mercks-keytruda-pembrolizumab-combination-chemotherapy-met-primary-endpoint-pr  Note this was success for mTBC, with 800+ patient enrollment. Also note the 1000+ ongoing clinical trial for Keytruda, vs CytoDyn’s single trial. The statement in the article that cancer treatment is changing in 30 day is 100% ridiculous. While I don’t think CytoDyn will sell any product at all in 2020, there is virtually zero chance they will commercialize for cancer. 

The Coronavirus indication is a complete non starter. A quick google anyone can see many realistic candidates being investigated/trialed, none are cytodyn’s option.

Viewing the CytoDyn video attached to this page, I noticed the CEO mentioned HIV was the top indication for the drug. He is right. I think the upside is detailed in the Culper report. I have some insight on the upcoming competition in this market.

Fire away with comments, questions, and criticism.

I didn't know that Cytodyn had paid for that article but I know they've done so in the past and am not surprised to see it again.  It's tough for small companies to get media exposure and paying for articles, while not ideal, is a marketing strategy.  However,  unlike the Culper "reports", the information in those articles is provided by management and therefore must represent their honest beliefs--otherwise they risk shareholder lawsuits and SEC sanctions.  

Culper, on the other hand, has no reason to tell the truth.  They are hidden behind a website with no information as to who they are.  Some have linked them to Germany but there's nothing to verify that either.  I believe their "report" is full of lies and is a blatant attempt to manipulate the stock price down.  Using their report as a source of your investment thesis is a very dangerous undertaking and I'd urge you tread lightly.  

I will say that I think we are to the point where CYDY has to produce to quiet the short selling crowd.  I believe the filing of their BLA, hopefully before month end, will be one catalyst.  Another will be the Coronavirus treatment.  Despite your inability to locate it with a Google search, it is real and the trial is slated to start.  

I agree with you that the 30-day window for changing cancer is more than aggressive, your statement that there's virtually zero chance they will commercialize for cancer is equally ridiculous and somewhat naive.  Also, seemingly heavily influenced by the Culper report.  The most important criterion the FDA looks at is the safety data.  CYDY has had ~840 people take their drug without any of them experiencing any kind of adverse side effect.  That safety data is transferable for cancer, and the Chinese FDA looked at that data when evaluating and then accepting Leronlimab for possible Coronavirus treatment.  The compassionate use designation granted by the FDA for metastatic breast cancer was given in large part because the drug is so safe.  They now have data from 4 patients and it's spectacular.  Yes, you can say that 4 patients is a small sample but when does the data become meaningful in your opinion?  The FDA has a breakthrough designation application that it's evaluating and they can't ignore the results--elimination of CTCs and reduction in tumor size.  The 4 patients who have taken Lironlimab have a significantly better life expectancy and that cannot be ignored.

What's your axe in this fight?  I find it more than a little suspicious that your first posts here are to slam CYDY.  Please explain how you got here and what your connection is to Culper, any competitor of CYDY etc.

Edited by chet
  • Thanks 1

Share this post


Link to post
Share on other sites
3 hours ago, Punxsutawney Phil said:

Fantasy football advice

Yes. I’ve mentioned this before, I’ve been a subscriber to this site for some time. Lurking on this thread, I investigated CYDY with interest to invest like I’m sure others have and came to a different conclusion. I’ve worked for big Pharma drug development for 25+ years and thought I would share my insights. So my “axe” is to have an interesting discussion and put my thoughts on the record, just like everyone else who contributes.

Also, I find the discussion here more nuanced than a typical stock board.

I’ve been around the ffa long enough to know about a guy who disappeared after a bet on the 2016 election.

  • Like 5

Share this post


Link to post
Share on other sites
5 hours ago, chet said:

I didn't know that Cytodyn had paid for that article but I know they've done so in the past and am not surprised to see it again.  It's tough for small companies to get media exposure and paying for articles, while not ideal, is a marketing strategy.  However,  unlike the Culper "reports", the information in those articles is provided by management and therefore must represent their honest beliefs--otherwise they risk shareholder lawsuits and SEC sanctions.  

Culper, on the other hand, has no reason to tell the truth.  They are hidden behind a website with no information as to who they are.  Some have linked them to Germany but there's nothing to verify that either.  I believe their "report" is full of lies and is a blatant attempt to manipulate the stock price down.  Using their report as a source of your investment thesis is a very dangerous undertaking and I'd urge you tread lightly.  

I will say that I think we are to the point where CYDY has to produce to quiet the short selling crowd.  I believe the filing of their BLA, hopefully before month end, will be one catalyst.  Another will be the Coronavirus treatment.  Despite your inability to locate it with a Google search, it is real and the trial is slated to start.  

I agree with you that the 30-day window for changing cancer is more than aggressive, your statement that there's virtually zero chance they will commercialize for cancer is equally ridiculous and somewhat naive.  Also, seemingly heavily influenced by the Culper report.  The most important criterion the FDA looks at is the safety data.  CYDY has had ~840 people take their drug without any of them experiencing any kind of adverse side effect.  That safety data is transferable for cancer, and the Chinese FDA looked at that data when evaluating and then accepting Leronlimab for possible Coronavirus treatment.  The compassionate use designation granted by the FDA for metastatic breast cancer was given in large part because the drug is so safe.  They now have data from 4 patients and it's spectacular.  Yes, you can say that 4 patients is a small sample but when does the data become meaningful in your opinion?  The FDA has a breakthrough designation application that it's evaluating and they can't ignore the results--elimination of CTCs and reduction in tumor size.  The 4 patients who have taken Lironlimab have a significantly better life expectancy and that cannot be ignored.

What's your axe in this fight?  I find it more than a little suspicious that your first posts here are to slam CYDY.  Please explain how you got here and what your connection is to Culper, any competitor of CYDY etc.

It is way more suspicious the way you are so defensive to anyone who doesn't like CYDY and the way you are constantly promoting the stock.  I hope you are right and the stock does great for you guys but I wouldn't touch it.

  • Thinking 1

Share this post


Link to post
Share on other sites
16 hours ago, stbugs said:

All my positions are long term so I usually let them ride. One of my stocks went up 18% today and it’s up @ 35% in 3 weeks. I’m hoping for multiples in 5 years so a nice day but not going anywhere. Still kicking myself for not throwing the rest of my cash in back in October or even 3 weeks ago. I’m happy with the returns on the investments but it’d be better to have more positions and be a bit more diversified. Again, I’m looking really long term. I’ve got more than enough cash for a while and I sure as #### don’t want to pay income tax on capital gains. That’s crazy.

Actually, definitely think about that. If you make a decent wage, you are paying federal and I think state taxes on that 14% if you sell it right away. That could be 5-6% gains gone.

Yea, I'm a holder... I thought this one through last night and I'll buy on weakness, wouldn't even mind that.

Share this post


Link to post
Share on other sites

I'm on the CYDY train too. I don't think there is any way to get real concrete information on a company like that; they're a pink sheet pharma startup, what do we really expect? Gonna go digging through Seeking Alpha comments and try and decipher what is true and what isn't?

I've got enough that I'll be happy if it has a Gilead like rise in the next decade, but I won't lose sleep if they go bankrupt. 

Personally, I see no reason for @chet to be delivering any false information here and fully take him at face value with his belief.

My gut says there are a ton of weak hands in this stock, and if the price stays in a similar range for too long, it will bleed as these weak holders will try to repurpose funds elsewhere. It is what it is.

  • Like 1

Share this post


Link to post
Share on other sites
37 minutes ago, Sneegor said:

It is way more suspicious the way you are so defensive to anyone who doesn't like CYDY and the way you are constantly promoting the stock.  I hope you are right and the stock does great for you guys but I wouldn't touch it.

Not sure why that’s suspicious, @chet believes in it and his advise has let a few of us to jump in and take a risk.  Defending something he believes in is hardly suspicious.  On the other hand a new member jumping in to warn us right at the same time the stock had what looks to be an event of shorters hitting the stock causing a dip is suspicious.  I have no idea if either guys legit, both are internet strangers.  But one has a long history here and a good rep, the other doesn’t. 

To be clear, I’m not throwing any shade at @Whyatt.  His posts are rational, not personally attacking and don’t come across as troll-ish.  He could very well be a good guy with only the best of intentions, and I appreciate his opinions here.  But imo if picking one to be the one who looks suspicious, the choice is pretty clear. 

Edited by dkp993
  • Like 1
  • Thanks 1

Share this post


Link to post
Share on other sites

@Whyatt @chet

CYDY: A quick look at financials show following cash on hand:

Feb 2019 $1.59mm;

May 2019 $2.61mm;

Aug 2019 $1.8mm;

Nov 2019 $409k+.

1) Any idea what transpired from 1st to 2nd Q to create that +$1.02mm spike?

2) They burned through almost $1.4mm in last quarter noted above. Any idea where it went?

3) since they burn through $4-5mm in cash per year, when will they need to raise cash again and how will they raise this s cash? Take on debt? Issue new shares? Sell shares that the company owns?

I have no view on this company. Just trying to learn how these small biotechs survive. Thanks

 

 

Share this post


Link to post
Share on other sites
41 minutes ago, Whyatt said:

 

I’ve been around the ffa long enough to know about a guy who disappeared after a bet on the 2016 election.

Well he’s legit 

  • Like 3
  • Laughing 2

Share this post


Link to post
Share on other sites
39 minutes ago, Sneegor said:

It is way more suspicious the way you are so defensive to anyone who doesn't like CYDY and the way you are constantly promoting the stock.  I hope you are right and the stock does great for you guys but I wouldn't touch it.

I guess I am defensive when it comes to a group like Culper research who hides behind their website, publishes lies and misleading info and never has to answer for their claims.  I have nothing against short sellers but I do not like people who try to manipulate the stock market.  I don't mind differing opinions as long as both are presented in good faith.

  • Thanks 2

Share this post


Link to post
Share on other sites
2 minutes ago, Rattle and Hum said:

@Whyatt @chet

CYDY: A quick look at financials show following cash on hand:

Feb 2019 $1.59mm;

May 2019 $2.61mm;

Aug 2019 $1.8mm;

Nov 2019 $409k+.

1) Any idea what transpired from 1st to 2nd Q to create that +$1.02mm spike?

2) They burned through almost $1.4mm in last quarter noted above. Any idea where it went?

3) since they burn through $4-5mm in cash per year, when will they need to raise cash again and how will they raise this s cash? Take on debt? Issue new shares? Sell shares that the company owns?

I have no view on this company. Just trying to learn how these small biotechs survive. Thanks

 

 

They've had to do micro raises since they don't produce any revenue yet.  After the recent stock spike, many people exercised their warrants which caused a cash inflow to the company.  Also, they have an $87.5MM milestone distribution agreement with Vyera which gave them ~$4.5MM in the last 6-8 weeks.  

  • Thanks 1

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.